Decreased apoptosis during CAR-mediated hepatoprotection against lithocholic acid-induced liver injury in mice
- 20 March 2009
- journal article
- Published by Elsevier in Toxicology Letters
- Vol. 188 (1) , 38-44
- https://doi.org/10.1016/j.toxlet.2009.03.005
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The Nrf2 Activator Oltipraz Also Activates the Constitutive Androstane ReceptorDrug Metabolism and Disposition, 2008
- Minimal Role of Hepatic Transporters in the Hepatoprotection against LCA-Induced Intrahepatic CholestasisToxicological Sciences, 2007
- Fortilin binds Ca2+ and blocks Ca2+-dependent apoptosisin vivoBiochemical Journal, 2007
- Hepatoprotective role of PXR activation and MRP3 in cholic acid‐induced cholestasisBritish Journal of Pharmacology, 2007
- Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas-induced murine liver injury by altering Bcl-2 proteinsHepatology, 2006
- Apoptosis: a mechanism of acute and chronic liver injuryGut, 2005
- The Constitutive Androstane Receptor and Pregnane X Receptor Function Coordinately to Prevent Bile Acid-induced HepatotoxicityJournal of Biological Chemistry, 2004
- A Novel Constitutive Androstane Receptor-Mediated and CYP3A-Independent Pathway of Bile Acid DetoxificationMolecular Pharmacology, 2004
- Prevention of bile acid-induced apoptosis by betaine in rat liverHepatology, 2002
- Inhibition of dimethylnitrosamine-induced liver fibrosis by [5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione] (oltipraz) in rats: suppression of transforming growth factor-β1 and tumor necrosis factor-α expressionChemico-Biological Interactions, 2002